ENFit Syringes Market Revenue to Attain USD 1,379.46 Mn by 2033

08 Aug 2025

Share :

Table of Content

1. ENFit Syringes Market Revenue and Trends 2025 to 2033 2. What are the Key Drivers of the ENFit Syringes Market? 3. Segment Outlook 4. Regional Insights 5. ENFit Syringes Market Coverage 6. Enfit Syringes Market Key Players

ENFit Syringes Market Revenue and Trends 2025 to 2033

The global ENFit syringes market revenue was valued at USD 849.97 million in 2025 and is expected to attain around USD 1,379.46 million by 2033, growing at a CAGR of 6.24% during forecast period. The growth of the market is driven by stringent patient safety regulations, rise in chronic disease cases, and growing demand for accurate, secure enteral feeding solutions.

What are the Key Drivers of the ENFit Syringes Market?

The market for ENFit syringes is experiencing robust growth, largely due to several factors. The shift toward standardized enteral feeding systems is driven by global efforts to enhance patient safety, emphasized on ISO 80369-3, which focuses on enteral feeding and the adoption of ENFit devices. The increasing prevalence of chronic illnesses, such as cancer and neurological disorders, is driving the need for long-term nutritional support through enteral feeding. These specialized medical devices reduce the risk of accidental misconnections between feeding tubes and intravenous lines, ensuring patient safety. Furthermore, increased awareness among healthcare professionals about the risks associated with misconnections is accelerating the adoption of ENFit syringes. Moreover, innovation in syringe design creates immense opportunities in the market.

Segment Outlook

• By syringe size, the 60 ml and above segment held the largest share of the market in 2024 due to its large volume and widespread clinical applications.
• By usage type, the disposable ENFit syringes segment dominated the market in 2024, due to their high safety and hygiene. The growing emphasis on infection control and the increasing preference for single-use medical devices bolster segmental growth.
• By tip type, the standard tip ENFit syringes segment contributed the largest market share in 2024. This is mainly due to their universal compatibility and ease of use.
• By material type, the polypropylene segment led the market with a major share in 2024 due to its durability, chemical resistance, cost-effectiveness, and guaranteed medical-grade safety.
• By end-user, hospitals generated the largest revenue share in 2024. This is due to their high patient volume and a strong emphasis on safety compliance. These settings are often equipped with advanced infrastructure, including ENFit syringes, attracting more patients.
• By distribution channel, the direct tenders segment sustained dominance in the market by holding the biggest market share in 2024, resulting from bulk procurement and cost efficiency. This channel enables manufacturers to have direct communication with end-users, providing specialized services.
• By application, the nutrition delivery segment continues to dominate the market because the enteral feeding needs are significantly rising, and healthcare professionals are focusing on safe, precise dosing administration. The increasing prevalence of chronic diseases, malnutrition, and swallowing disorders spurred demand for safe and reliable enteral feeding options.
• By patient group, the adults segment held the greatest market share in 2024, due to the higher prevalence of chronic disease among this age group and an increased demand for long-term enteral nutrition.

Regional Insights

North America registered dominance in the ENFit syringes market in 2024 due to its well-established healthcare systems, knowledge of safe enteral practices, and a willingness to accept ISO-compliant devices. The presence of a large number of market players and rising product innovation further spur market growth in the region. Meanwhile, Asia-Pacific is emerging as the fastest-growing region in the market, driven by improved healthcare systems, increasing healthcare investment, and an expanding patient population requiring enteral nutrition.

ENFit Syringes Market Coverage

Recent Development

• On September 6, 2024, the FDA approved nimodipine (Nymalize) oral solution prefilled in a 30 mg/5 mL ENFit syringe, offering improved safety and standardized delivery. (Source: https://www.drugtopics.com)

Enfit Syringes Market Key Players

• BD (Becton, Dickinson and Company)
• Cardinal Health
• Baxter International
• Medtronic
• Terumo Corporation
• Vygon SA
• B. Braun Melsungen AG
• Moog Inc.
• Smiths Medical (ICU Medical)
• Avanos Medical
• Medela AG
• GBUK Group Ltd
• Amsino International, Inc.
• Kentec Medical, Inc.
• NeoMed Inc.
• Applied Medical Technology, Inc.
• Vesco Medical, LLC
• Dynarex Corporation
• HMC Group
• Cair LGL

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6548

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344